Billionaires Holding VNDA

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 33.9M
    Shares Outstanding

  • 700.94M
    Market Cap

News & Insights

ABOUT

VNDA

Vanda Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development and commercialization of pharmaceutical products. Its product portfolio includes HETLIOZ, a product for the treatment of Non-24-Hour Sleep-Wake Disorder; Fanapt, a product for the treatment of schizophrenia; an...

Germany’s Economy Revs Up

NEWS

The Morning Ledger: WTO Deadline Could Hurt Firms with Supply Chains in China

READ MORE